Cargando…

S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML

Detalles Bibliográficos
Autores principales:	Montesinos, Pau, Rodríguez-Veiga, Rebeca, Bergua Burgues, Juan Miguel, Algarra, Lorenzo, Botella, Carmen, Josè Antonio, Perez Simon, Bernal, Teresa, Tormo, Mar, Robles, Maria Calbacho, Salamero, Olga, Serrano, Josefina, Noriega, Victor, López-López, Juan Antonio, Polo, Susana Vives, Colorado, Mercedes, Lorenzo, Jose Luis Lopez, Vidriales, María Belén, Boyero, Raimundo Garcia, Olave, Mayte, Herrera-Puente, Pilar, Arce, Olga, Garcia, Manuel Barrios, Jose Sayas Lloris, Maria, Polo, Marta, Isabel Gomez Roncero, Maria, Barragan, Eva, Ayala Diaz, Rosa, Carmen Chillon, Maria, Jose Calasanz, Maria, Boluda, Blanca, Martinez-Cuadrón, David, Labrador, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Oral Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428252/ http://dx.doi.org/10.1097/01.HS9.0000967432.73477.1d

Ejemplares similares

P531: MIDOSTAURIN PLUS 7 + 3 OR QUIZARTINIB PLUS 7 + 3 IN FLT3-ITD MUTATED AML
por: Tormo, Mar, et al.
Publicado: (2023)

Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia
por: Martínez-Cuadrón, David, et al.
Publicado: (2022)

The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial
por: Ayala, Rosa, et al.
Publicado: (2021)

Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry
por: Sargas, Claudia, et al.
Publicado: (2023)

No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group
por: Castaño-Bonilla, Tamara, et al.
Publicado: (2022)

Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports
por: Martínez-Cuadrón, David, et al.
Publicado: (2020)

P498: INCIDENCE, RISK FACTORS AND OUTCOMES OF SECOND NEOPLASMS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: THE PETHEMA-PALG EXPERIENCE.
por: Sobas, Marta, et al.
Publicado: (2023)

S132: UPDATED RESULTS OF VEN-A-QUI STUDY: A PHASE 1-2 TRIAL TO ASSESS THE SAFETY AND EFFICACY OF TRIPLETS FOR NEWLY DIAGNOSED UNFIT AML PATIENTS: AZACITIDINE OR LOW-DOSE CYTARABINE WITH VENETOCLAX AND QUIZARTINIB
por: Miguel Bergua Burgues, Juan, et al.
Publicado: (2023)

PB1779: FLT3-ITD MUTATION CHARACTERIZATION WITH CLASSICAL PCR METHODOLOGY VERSUS CAPTURE- AND AMPLICON-BASED NGS PLATFORMS: A PETHEMA NGS-AML PROJECT
por: Bilbao, Cristina, et al.
Publicado: (2023)

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens
por: Castaño-Bonilla, Tamara, et al.
Publicado: (2021)

Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group
por: Sargas, Claudia, et al.
Publicado: (2023)

Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia
por: Simoes, Catia, et al.
Publicado: (2022)

Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study
por: Ayala, Rosa, et al.
Publicado: (2022)

Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study
por: Martínez-Cuadrón, David, et al.
Publicado: (2022)

Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry
por: Martínez, Pilar, et al.
Publicado: (2020)

Effect of Food on the Pharmacokinetics of Quizartinib
por: Li, Jianke, et al.
Publicado: (2020)

The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients
por: Villar, Sara, et al.
Publicado: (2022)

Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
por: Sargas, Claudia, et al.
Publicado: (2020)

Sleeping through the storm: Preventing myelosuppression with quizartinib
por: Taylor, Samuel J., et al.
Publicado: (2017)

Repurposing of Ibrutinib and Quizartinib as potent inhibitors of necroptosis
por: Huang, Fangmin, et al.
Publicado: (2023)

A Combination of a Vibrational Electromagnetic Energy Harvester and a Giant Magnetoimpedance (GMI) Sensor
por: Beato-López, Juan Jesús, et al.
Publicado: (2020)

FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients—efficacy and microbiologic safety
por: Moreno, Ainhoa Fernández, et al.
Publicado: (2023)

Cocoa Coproducts-Based and Walnut Oil Gelled Emulsion as Animal Fat Replacer and Healthy Bioactive Source in Beef Burgers
por: Botella-Martinez, Carmen, et al.
Publicado: (2021)

Clinical outcomes after CPX‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry
por: Bernal, Teresa, et al.
Publicado: (2023)

Intracellular mechanisms of solar water disinfection
por: Castro-Alférez, María, et al.
Publicado: (2016)

Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain
por: Ribera, Josep-Maria, et al.
Publicado: (2021)

Marble Waste Sludges as Effective Nanomaterials for Cu (II) Adsorption in Aqueous Media
por: Ramos, Ventura Castillo, et al.
Publicado: (2021)

Life Cycle Assessment of Cement Production with Marble Waste Sludges
por: Sánchez, Antonio Ruiz, et al.
Publicado: (2021)

Relationship between knee alignment in asymptomatic subjects and flexibility of the main muscles that are functionally related to the knee
por: Lucha-López, María Orosia, et al.
Publicado: (2018)

Rossellomorea arthrocnemi sp. nov., a novel plant growth-promoting bacterium used in heavy metal polluted soils as a phytoremediation tool
por: Navarro-Torre, Salvadora, et al.
Publicado: (2021)

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design
por: Aguilera-Diaz, Almudena, et al.
Publicado: (2020)

3D Master Toothguide Is Adequate to Subjective Shade Selection?
por: Gómez-Polo, Cristina, et al.
Publicado: (2022)

Advances in Natural Antioxidants for Food Improvement
por: López-Pedrouso, María, et al.
Publicado: (2022)

Hematoma del músculo psoas bilateral por infección SARS-CoV-2 en paciente crítico
por: Simón Polo, Elena, et al.
Publicado: (2022)

Bilateral psoas muscle hematoma in critical patient with COVID-19()
por: Simón Polo, Elena, et al.
Publicado: (2022)

Economic Problems and Loneliness as Factors Related to Subjective Unmet Health Needs in People with Chronic Diseases and Dependency
por: López-Entrambasaguas, Olga María, et al.
Publicado: (2020)

Physical disease in schizophrenia: a population-based analysis in Spain
por: Bouza, Carmen, et al.
Publicado: (2010)

Influence of Pre-Harvest Bagging on the Incidence of Aulacaspis tubercularis Newstead (Hemiptera: Diaspididae) and Fruit Quality in Mango
por: del Pino, Modesto, et al.
Publicado: (2021)

Quizartinib (AC220): a promising option for acute myeloid leukemia
por: Zhou, Fang, et al.
Publicado: (2019)

Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience
por: Labrador, Jorge, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qqq66d2901js5vvam9baoijcnk